Safety and Efficacy of Tolvaptan in Korean Patients with Hyponatremia Caused by the Syndrome of Inappropriate Antidiuretic Hormone

Sang-Woong HAN; Joo-Hark YI; Kyung-Pyo KANG; Ha-Yeon KIM; Soo-Wan KIM; Hoon-Young CHOI; Sung-Kyu HA; Gheun-Ho KIM; Yang-Wook KIM; Kyung-Hwan JEONG; Sug-Kyun SHIN; Ho-Jung KIM.
Journal of Korean Medical Science ; : e112-2018.
Artículo en Inglés | WPRIM | ID: wpr-714128

Documentos relacionados

  1. Safety and Efficacy of Tolvaptan in Korean Patients with Hyponatremia Caused by the Syndrome of Inappropriate Antidiuretic Hormone.
  2. Syndrome of inappropriate antidiuretic hormone secretion as an adverse reaction of ciprofloxacin: a case report and literature review.
  3. Open-label, multicenter, dose-titration study to determine the efficacy and safety of tolvaptan in Japanese patients with hyponatremia secondary to syndrome of inappropriate secretion of antidiuretic hormone.
  4. A case of linezolid-induced SIADH in elderly and a review of the literature.
  5. Syndrome of inappropriate antidiuretic hormone secretion is associated with different proton pump inhibitor use: a pharmacovigilance study.
  6. Variations in daily urine solute output in patients with NDI, CDI, SIADH, and NSIAD: Clinical implications.
  7. A retrospective study on tolvaptan prescription in clinical practice in patients with syndrome of inappropriate secretion of antidiuretic hormone (SIADH) using the Japanese claims database.
  8. Use of Urea for the Syndrome of Inappropriate Secretion of Antidiuretic Hormone: A Systematic Review.
  9. Artificial Syndrome of Inappropriate Antidiuresis Model as Potential Use for Diagnostic and Therapeutic Strategies.
  10. The management and outcome of hyponatraemia following transsphenoidal surgery: a retrospective observational study.